Cannabidivarin, formerly known as CBDV and GWP-42006, is discontinued (DEA controlled substance). It is a TRPV1/V2/A1 agonist potentially for treatment of epilepsy. References: Hill TD, Cascio MG, Romano B, Duncan M, Pertwee RG, Williams CM, Whalley BJ, Hill AJ. Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. Br J Pharmacol. 2013 Oct;170(3):679-92. doi: 10.1111/bph.12321. PubMed PMID: 23902406; PubMed Central PMCID: PMC3792005.

纯度：≥98%

CAS：24274-48-4